
Althera Laboratories Announces GMP Approval of State-of-the-Art Pharmaceutical Manufacturing Facility
New facility in Mysuru, India, set to produce one billion oral doses annually, strengthening Althera’s supply chain for cardiovascular and metabolic medicines. DUBLIN, DUBLIN, IRELAND, September 9, 2025 /EINPresswire.com/ -- Althera Laboratories Limited …